Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Endocr Relat Cancer. 2020 Aug;27(8):T41–T52. doi: 10.1530/ERC-19-0435

Table 3.

Current gaps recognizing in research and clinical practice of metastatic PPGLs

Risk assessment models
Guidelines for care of metastatic PPGL
Surveillance programs for mutation carriers
Access to treatment opportunities
Genetic testing: not widely available
Opportunities for communication and discussion of care/surveillance of specific cases